XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
Research and development $ 6,448 $ 6,085
General and administrative 5,040 1,711
Total operating expenses 11,488 7,796
Loss from operations (11,488) (7,796)
Interest income 39 108
Change in fair value of preferred stock tranche obligation   (106)
Net loss (11,449) (7,794)
Cumulative dividends on convertible preferred stock   (1,299)
Net loss attributable to common stockholders $ (11,449) $ (9,093)
Net loss per common share—basic and diluted $ (0.54) $ (6.61)
Weighted-average number of shares outstanding used in computing net loss per common share—basic and diluted 21,020,378 1,375,177